The Role of Cardiovascular Imaging and Serum Biomarkers in Identifying Cardiotoxicity Related to Cancer Therapeutics
Authors
Ali Agha
McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas
Abdulrazzak Zarifa
University of Texas MD Anderson Cancer Center, Houston, Texas
Juan Lopez-Mattei
University of Texas MD Anderson Cancer Center, Houston, Texas
DOI: https://doi.org/10.14797/mdcj-15-4-258 | Journal eISSN: 1947-6108
Language: English
Page range: 258 - 266
Published on: Oct 1, 2019
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2019 Ali Agha, Abdulrazzak Zarifa, Peter Kim, Cezar Iliescu, Greg Gladish, Saamir Hassan, Nicolas Palaskas, Jean B. Durand, Yang Lu, Juan Lopez-Mattei, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.